课题基金 / 基金详情

Evaluation of bioadhesive berry gels for oral cancer chemoprevention

Evaluation of bioadhesive berry gels for oral cancer chemoprevention
生物粘附浆果凝胶用于口腔癌化学预防的评价
批准号:
7382405
负责人:
Susan R Mallery
金额:
$21.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-07 至 2010-02-28
关键词:
AddressAdverse effectsAffectAnimal ModelAnthocyaninsAnthracenesApoptosisApoptoticAttenuatedBenzo(a)pyreneBerryBiological MarkersCarcinomaCell LineCheek structureChemopreventionChemopreventive AgentClinicalClinical ChemopreventionClinical ResearchClinical TrialsComplicationConduct Clinical TrialsCytoprotectionDailyDataDevelopmentDiseaseDisease ManagementDisease regressionDoseDrug FormulationsDrug KineticsEarly DiagnosisEpoxy CompoundsEsophagealEsophagusEthanolEvaluationEventFoundationsFreeze DryingFutureGelGene ExpressionGenerationsGlycolGoalsGrantGrowthHamstersHealthHumanHuman VolunteersIn VitroIndividual DifferencesInduction of ApoptosisInflammationInterventionIntraepithelial NeoplasiaInvestigationKnowledgeLaboratoriesLesionLifeMalignant Epithelial CellMalignant NeoplasmsMediatingMesocricetus auratusMetabolismMethodsMucositisNitrosaminesOperative Surgical ProceduresOralOral Surgical ProceduresOral cavityOral mucous membrane structureOutcomeOxidation-ReductionParentsPathway interactionsPatientsPersonal SatisfactionPersonsPhasePhosphotransferasesPhytochemicalPlacebo ControlPrecancerous ConditionsPremalignantProductionPropertyProtein IsoformsPublic HealthRaspberriesRattusRecurrenceRelative (related person)ResistanceReverse Transcriptase Polymerase Chain ReactionSalivaSeriesSiteSquamous cell carcinomaStagingSurfaceSurvival RateTestingTherapeutic IndexTimeTissuesTopical applicationToxic effectTranscription Factor AP-1Treatment ProtocolsUrineVitamin AWaterWeekactivating transcription factorangiogenesisanthraceneattenuationbasecell growthclinically relevantcyanidincytokinedaydesigndosageembryo cellfightinghuman NOS2A proteinhuman tissueimprovedin vivoindexinginterestkeratinocytemalignant mouth neoplasmmouth squamous cell carcinomanitrosobenzylmethylamineoral carcinogenesisoral cavity epitheliumoral lesionoral tissueoutcome forecastperipheral bloodpreventtumorigenesis

项目摘要

项目成果

Susan R Mallery的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): Despite concerted efforts to improve therapy, five year survival rates for patients with advanced stage oral squamous cell carcinoma (oral SCC) remain discouragingly low. Early detection combined with strategies for local intervention, such as chemoprevention prior to oral SCC development, could dramatically improve clinical outcomes. Results of previously conducted oral cavity chemoprevention trials, however, have not been highly promising. Notably, the majority of previous oral chemoprevention trials administered agents systemically. For targeted disease management, local delivery methods have several advantages relative to systemic administration that include delivery of therapeutically relevant concentrations directly to the lesional site. Recent studies from our laboratories have shown that black raspberries possess cancer preventing properties at both the in vitro and in vivo levels. Dietary administration of freeze-dried black raspberries (FBR) successfully inhibited both esophageal and cheek pouch carcinoma in animal models. Likewise, in vitro studies have shown both FBR and black raspberry extracts regulate cell growth by a variety of mechanisms that include scavenging of reactive species, initiation of apoptosis and induction of differentiation. For persons with the premalignant condition, oral epithelial dysplasia, chemoprevention will likely be necessary for the remainder of their lives. Therefore, identification of nontoxic, effective agents delivered in formulations that provide maximal concentrations at the lesional site, is necessary to improve patient prognosis. Based on our results we hypothesize that berry gels elicit their chemopreventive effects by attenuation of proinflammatory and proproliferative pathways while concurrently stimulating growth regulatory mechanisms such as differentiation and apoptosis. We also speculate that oral mucosal phytochemical metabolism modulates chemopreventive effects of the topically applied parent compounds. Specific Aim 1 studies will evaluate the ability of optimized berry gel formulations to affect: 1) tissue generation of reactive species, 2) production of proangiogenic molecules, and 3) proliferation, differentiation and apoptotic indices of surface oral epithelium. Studies proposed for Specific Aim 2 will evaluate the capacity for human oral mucosa to: 1) metabolize selected FBR phenolic compounds, 2) modulate chemopreventive properties of FBR parent compounds. Public health relevance: These studies will test bioadhesive gels, which contain naturally occurring cancer fighting compounds to determine the gels' chemopreventive (cancer preventing) abilities on oral tissues. Oral cancer remains a significant health problem in the U.S. Even for those persons who can be cured, the necessary surgery is debilitating and often disfiguring. These studies will test the effects of bioadhesive gels, which contain naturally occurring cancer fighting compounds, to determine the gels' chemopreventive (cancer fighting) abilities on explants of human oral mouth tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multidisciplinary Research Training in Dental, Oral, and Craniofacial Sciences (MARTDOCS)
  • 批准号:
    10711411
  • 项目类别:
  • 资助金额:
    $52.54万
  • 财政年份:
    2023
  • 负责人:
    Susan R Mallery
  • 依托单位:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
  • 批准号:
    10540811
  • 项目类别:
  • 资助金额:
    $58.37万
  • 财政年份:
    2021
  • 负责人:
    Susan R Mallery
  • 依托单位:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
  • 批准号:
    10359559
  • 项目类别:
  • 资助金额:
    $58.16万
  • 财政年份:
    2021
  • 负责人:
    Susan R Mallery
  • 依托单位:
Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions
  • 批准号:
    10321591
  • 项目类别:
  • 资助金额:
    $52.69万
  • 财政年份:
    2019
  • 负责人:
    Susan R Mallery
  • 依托单位:
海外基金